Yu Ling Luo
Vermögen: 108 Mio $ am 30.09.2026
Vermögen: 108 Mio $ am 30.09.2026
Yu Ling Luo was the founder of Advanced Cell Diagnostics, Inc., founded in 2006, serving as President, Chief Executive Officer & Director.
Dr. Luo is the founder of Alamar Biosciences, Inc., founded in 2018, holding the title of Chairman & Chief Executive Officer.
Dr. Luo is the founder of Alamar Biosciences, Inc. (California), founded in 2018, holding the title of Chairman & Chief Executive Officer.
Dr. Luo is also the founder of Panomics LLC..
Dr. Luo is currently a Venture Partner at IIF Management Co. LLC since 2020.
Former positions include Scientist at Exelixis, Inc. and President at Bionostics, Inc. from 2016 to 2018.
Education includes a doctorate from Case Western Reserve University and an undergraduate degree from the University of Science & Technology of China.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 3’164’726 ( 4.56% ) | 108 Mio $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ALAMAR BIOSCIENCES, INC. | Vorstandsvorsitzender | 01.07.2018 |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance Illumina Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of life science tools, diagnostics, therapeutics, digital health and sustainability sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01.01.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
Bio-Techne
Bio-Techne Medical SpecialtiesHealth Technology Provides liquid quality control standards used to confirm the performance of medical testing devices | Private Equity Investor | 01.02.2018 |
Alamar Biosciences, Inc.
Alamar Biosciences, Inc. Medical SpecialtiesHealth Technology In vitro diagnostics | Vorstandsvorsitzender | - |
Panomics LLC
Panomics LLC Miscellaneous Commercial ServicesCommercial Services Provides life sciences research reagents | Gründer | - |
| EXELIXIS, INC. | Corporate Officer/Principal | - |
Advanced Cell Diagnostics, Inc.
Advanced Cell Diagnostics, Inc. BiotechnologyHealth Technology Develops cell and tissue based diagnostic tests | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Exelixis, Inc.
Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Panomics LLC
Panomics LLC Miscellaneous Commercial ServicesCommercial Services Provides life sciences research reagents | Commercial Services |
Alamar Biosciences, Inc.
Alamar Biosciences, Inc. Medical SpecialtiesHealth Technology In vitro diagnostics | Health Technology |
Bio-Techne
Bio-Techne Medical SpecialtiesHealth Technology Provides liquid quality control standards used to confirm the performance of medical testing devices | Health Technology |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advanced Cell Diagnostics, Inc.
Advanced Cell Diagnostics, Inc. BiotechnologyHealth Technology Develops cell and tissue based diagnostic tests | Health Technology |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance Illumina Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of life science tools, diagnostics, therapeutics, digital health and sustainability sectors. It provides financing for early stage capital requirements. | Finance |
Alamar Biosciences, Inc. (California)
Alamar Biosciences, Inc. (California) BiotechnologyHealth Technology Develops a proteomic liquid biopsy platform and sells instruments, consumables & services for the early detection of diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen